Protein E7(43-62)
Cat.No:CLP0736 Solarbio
CAS:143853-58-1
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
{{cart_num}}
My CartCAS:143853-58-1
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
Product Type | Peptides |
CAS | 143853-58-1 |
Sequence(1LC) | GQAEPDRAHYNIVTFCCKCD |
Sequence(3LC) | Gly-Gln-Ala-Glu-Pro-Asp-Arg-Ala-His-Tyr-Asn-Ile-Val-Thr-Phe-Cys-Cys-Lys-Cys-Asp |
Molecular Formula | C95H144N28O31S3 |
Molecular Weight | 2270.54 |
Purity | ≥95% |
Appearance | Lyophilized powder |
Salt Form | Trifluoroacetate salt |
Source | Synthetic |
Storage | Store at -20℃,2 years.(Avoid freeze/thaw cycles) |
Category/Label | Other Peptides |
Background | Protein E7(43-62) is an E7-derived peptide with anti-tumor effects (short peptide spanning the 43th to 62th amino acid residues in the E7 protein). |
In Vitro | undetected |
In Vivo | Using an E7-derived peptide Protein E7(43-62), 50% of mice (C57BL/6 mice bearing human papilloma virus (HPV) E6/7 TC-1 tumors) are tumor free 60 days after treatment with Protein E7(43-62)-polymeric nanoparticle (PC7A NP). |
Reference | [1] Min Luo, et al. A STING-activating Nanovaccine for Cancer Immunotherapy. Nat Nanotechnol. 2017 Jul;12(7):648-654. |
Unit | Bottle |
Specification | 1mg 5mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.